Home » Market News » DirectorsTalk Highlights » Wonder stem cell cure for heart failure
WideCells Group PLC

Wonder stem cell cure for heart failure

Millions of heart failure patients could be saved thanks to a new stem cell therapy being tested in Britain. Researchers revealed a breakthrough treatment that cuts out the need for operations by revitalising damaged tissue using cells harvested from a patient’s own blood.

Widecells Group (LON:WDC), are leading a transformation in cord blood banking and stem cell treatment; making cord blood banking more accessible through insurance coverage, and increasing the availability of cord blood for transplants.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.